Downregulation of Sperm-associated Antigen 5 Inhibits Melanoma Progression by Regulating Forkhead Box Protein M1/A Disintegrin and Metalloproteinase 17/NOTCH1 Signaling

Overview

Journal Bioengineered

Date 2022 Feb 9

PMID 35138218

Authors

Lin Dang

Cuiping Shi

Qianqian Zhang

Peiyu Liao

Yan Wang

Affiliations

Soon will be listed here.

Abstract

Sperm-associated antigen 5 (SPAG5) has been identified as a driver in several type of cancers. In this study, we aimed to reveal the role of SPAG5 in melanoma and clarify whether FOXM1 (forkhead box protein M1) /ADAM17 (A disintegrin and metalloproteinase 17) /NOTCH1 signaling was involved. The expression of SPAG5 in malignant melanoma (MM) tissues and matched normal tissues was detected using qRT-PCR, immunohistochemistry and Western blotting. Cell viability was tested using CCK-8 (Cell Count Kit-8), colony formation and EdU staining. Cell migration and epithelial to mesenchymal transition (EMT) were measured using transwell chambers and immunofluorescent staining. Cell cycle distribution and tumorigenesis were assessed by flow cytometry and in vivo tumor-bearing experiments, respectively. The results demonstrated that the expression of SPAG5 was increased in MM tissues and cells. Downregulation of SPAG5 inhibited cell viability, migration, invasion and EMT, and induced a G1-phase arrest. In addition, downregulation of SPAG5 decreased the expression of FOXM1, thereafter inhibiting the expression of ADAM17, NOTCH1 and HES1. Furthermore, deletion of SPAG5 expression decreased the tumorigenesis of MM A375 cells. In conclusion, this study demonstrated that SPAG5 was overexpressed in MM. Downregulation of SPAG5 repressed MM cell growth and EMT, which might be induced by inactivation of the FOXM1/ADAM17/NOTCH1 signaling.

Citing Articles

[Biological role of SPAG5 in the malignant proliferation of gastric cancer cells].

Pang Y, Liu Y, Chen S, Zhang J, Zeng J, Pan Y Nan Fang Yi Ke Da Xue Xue Bao. 2024; 44(8):1497-1507.

PMID: 39276045 PMC: 11378056. DOI: 10.12122/j.issn.1673-4254.2024.08.08.

Identification of key genes associated with cancer stem cell characteristics in Wilms' tumor based on bioinformatics analysis.

Su C, Zheng J, Chen S, Tuo J, Su J, Ou X Ann Transl Med. 2022; 10(22):1204.

PMID: 36544656 PMC: 9761159. DOI: 10.21037/atm-22-4477.

Curcumin Improves Keratinocyte Proliferation, Inflammation, and Oxidative Stress through Mediating the SPAG5/FOXM1 Axis in an Model of Actinic Dermatitis by Ultraviolet.

Chen Q, Tang Y, Deng H, Liang B, Li H, Li Z Dis Markers. 2022; 2022:5085183.

PMID: 36118675 PMC: 9481376. DOI: 10.1155/2022/5085183.

References

Xu S, Xiao Y, Zeng S, Zou Y, Qiu Q, Huang M . Piperlongumine inhibits the proliferation, migration and invasion of fibroblast-like synoviocytes from patients with rheumatoid arthritis. Inflamm Res. 2017; 67(3):233-243. DOI: 10.1007/s00011-017-1112-9. View

Ye Y, Huang S, Wu Y . UNBS5162 and amonafide inhibits tumor progression in human melanoma by the AKT/mTOR pathway. Cancer Manag Res. 2019; 11:2339-2348. PMC: 6434921. DOI: 10.2147/CMAR.S177623. View

Barrett C, Millena A, Khan S . TGF-β Effects on Prostate Cancer Cell Migration and Invasion Require FosB. Prostate. 2016; 77(1):72-81. PMC: 5286811. DOI: 10.1002/pros.23250. View

Abdel-Fatah T, Agarwal D, Liu D, Russell R, Rueda O, Liu K . SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis. Lancet Oncol. 2016; 17(7):1004-1018. DOI: 10.1016/S1470-2045(16)00174-1. View

Huang L, Chen J, Quan J, Xiang D . Rosmarinic acid inhibits proliferation and migration, promotes apoptosis and enhances cisplatin sensitivity of melanoma cells through inhibiting ADAM17/EGFR/AKT/GSK3β axis. Bioengineered. 2021; 12(1):3065-3076. PMC: 8806498. DOI: 10.1080/21655979.2021.1941699. View

Yang T, Tian S, Wang L, Wang Y, Zhao J . MicroRNA-367-3p overexpression represses the proliferation and invasion of cervical cancer cells through downregulation of SPAG5-mediated Wnt/β-catenin signalling. Clin Exp Pharmacol Physiol. 2019; 47(4):687-695. DOI: 10.1111/1440-1681.13222. View

Bozkulak E, Weinmaster G . Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling. Mol Cell Biol. 2009; 29(21):5679-95. PMC: 2772745. DOI: 10.1128/MCB.00406-09. View

Ma Z, Gao Y, Liu W, Zheng L, Jin B, Duan B . CD82 Suppresses ADAM17-Dependent E-Cadherin Cleavage and Cell Migration in Prostate Cancer. Dis Markers. 2020; 2020:8899924. PMC: 7654213. DOI: 10.1155/2020/8899924. View

Jiang J, Wang J, He X, Ma W, Sun L, Zhou Q . High expression of SPAG5 sustains the malignant growth and invasion of breast cancer cells through the activation of Wnt/β-catenin signalling. Clin Exp Pharmacol Physiol. 2019; 46(6):597-606. DOI: 10.1111/1440-1681.13082. View

10.

Zheng Y, Wang K, Wu Y, Chen Y, Chen X, Hu C . Pinocembrin induces ER stress mediated apoptosis and suppresses autophagy in melanoma cells. Cancer Lett. 2018; 431:31-42. DOI: 10.1016/j.canlet.2018.05.026. View

11.

He X, Wang J, Wei W, Shi M, Xin B, Zhang T . Hypoxia regulates ABCG2 activity through the activivation of ERK1/2/HIF-1α and contributes to chemoresistance in pancreatic cancer cells. Cancer Biol Ther. 2016; 17(2):188-98. PMC: 4847991. DOI: 10.1080/15384047.2016.1139228. View

12.

Liu G, Liu S, Cao G, Luo W, Li P, Wang S . SPAG5 contributes to the progression of gastric cancer by upregulation of Survivin depend on activating the wnt/β-catenin pathway. Exp Cell Res. 2019; 379(1):83-91. DOI: 10.1016/j.yexcr.2019.03.024. View

13.

Yang Y, Zhang M, Tian Q, Fu J, Yang X, Zhang C . SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma. Mol Cancer. 2018; 17(1):117. PMC: 6081940. DOI: 10.1186/s12943-018-0872-3. View

14.

Li Q, Wang Y, He J . MiR-133a-3p attenuates resistance of non-small cell lung cancer cells to gefitinib by targeting SPAG5. J Clin Lab Anal. 2021; 35(7):e23853. PMC: 8274984. DOI: 10.1002/jcla.23853. View

15.

Zhang M, Sha L, Hou N, Shi C, Tan L . High expression of sperm-associated antigen 5 correlates with poor survival in ovarian cancer. Biosci Rep. 2020; 40(2). PMC: 7007403. DOI: 10.1042/BSR20193087. View

16.

Liu J, Wang C, Ma X, Tian Y, Wang C, Fu Y . High expression of CCR5 in melanoma enhances epithelial-mesenchymal transition and metastasis via TGFβ1. J Pathol. 2018; 247(4):481-493. DOI: 10.1002/path.5207. View

17.

Fang W, Qian J, Wu Q, Chen Y, Yu G . ADAM-17 expression is enhanced by FoxM1 and is a poor prognostic sign in gastric carcinoma. J Surg Res. 2017; 220:223-233. DOI: 10.1016/j.jss.2017.06.032. View

18.

Zhang C, Han X, Xu X, Zhou Z, Chen X, Tang Y . FoxM1 drives ADAM17/EGFR activation loop to promote mesenchymal transition in glioblastoma. Cell Death Dis. 2018; 9(5):469. PMC: 5920065. DOI: 10.1038/s41419-018-0482-4. View

19.

Yuan L, Li J, Zhang L, Wang J, Wan T, Zhou Y . SPAG5 upregulation predicts poor prognosis in cervical cancer patients and alters sensitivity to taxol treatment via the mTOR signaling pathway. Cell Death Dis. 2014; 5:e1247. PMC: 4047857. DOI: 10.1038/cddis.2014.222. View

20.

Koo C, Muir K, Lam E . FOXM1: From cancer initiation to progression and treatment. Biochim Biophys Acta. 2011; 1819(1):28-37. DOI: 10.1016/j.bbagrm.2011.09.004. View